Robert Olstein's DGX Position Overview
Robert Olstein (via Olstein Capital Management, L.P.) currently holds 35,800 shares of Quest Diagnostics Incorporated (DGX) worth $7.02 M, representing 1.53% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 30 quarters.
Based on 13F filings, Robert Olstein has maintained a strategic position in DGX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2020, adding 40,000 shares. Largest reduction occurred in Q1 2015, reducing 59,000 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Olstein's Quest Diagnostics Incorporated (DGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Quest Diagnostics Incorporated (DGX) Trades by Robert Olstein
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -4,200 | Reduce 10.50% | 35,800 | $195.98 |
| Q2 2025 | -6,000 | Reduce 13.04% | 40,000 | $179.62 |
| Q1 2025 | -8,216 | Reduce 15.15% | 46,000 | $169.20 |
| Q4 2024 | -1,102 | Reduce 1.99% | 54,216 | $150.86 |
| Q3 2024 | -11,682 | Reduce 17.44% | 55,318 | $155.25 |
| Q1 2024 | +9,000 | Add 15.52% | 67,000 | $133.10 |
| Q4 2023 | -10,000 | Reduce 14.71% | 58,000 | $137.88 |
| Q3 2023 | +2,000 | Add 3.03% | 68,000 | $121.85 |
| Q2 2023 | +11,000 | Add 20.00% | 66,000 | $140.56 |
| Q1 2023 | +9,000 | Add 19.57% | 55,000 | $141.47 |
| Q4 2022 | -21,400 | Reduce 31.75% | 46,000 | $156.43 |
| Q2 2022 | -7,600 | Reduce 10.13% | 67,400 | $132.98 |
| Q1 2022 | +33,000 | Add 78.57% | 75,000 | $136.87 |
| Q4 2021 | -18,000 | Reduce 30.00% | 42,000 | $173.00 |
| Q3 2021 | -2,000 | Reduce 3.23% | 60,000 | $145.32 |
| Q1 2021 | +22,000 | Add 55.00% | 62,000 | $128.34 |
| Q4 2020 | +40,000 | New Buy | 40,000 | $119.18 |
| Q1 2015 | -59,000 | Sold Out | 0 | $0.00 |
| Q4 2014 | -23,000 | Reduce 28.05% | 59,000 | $67.07 |
| Q2 2014 | -18,000 | Reduce 18.00% | 82,000 | $58.70 |
| Q1 2014 | +7,000 | Add 7.53% | 100,000 | $57.92 |
| Q4 2013 | +10,000 | Add 12.05% | 93,000 | $53.54 |
| Q2 2013 | +83,001 | Add 0.00% | 83,000 | $60.63 |
Robert Olstein's Quest Diagnostics Incorporated Investment FAQs
Robert Olstein first purchased Quest Diagnostics Incorporated (DGX) in Q2 2013, acquiring 83,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein has held Quest Diagnostics Incorporated (DGX) for 30 quarters since Q2 2013.
Robert Olstein's largest addition to Quest Diagnostics Incorporated (DGX) was in Q2 2013, adding 83,000 shares worth $5.03 M.
According to the latest 13F filing for Q1 2026, Robert Olstein's firm, Olstein Capital Management, L.P., owns 35,800 shares of Quest Diagnostics Incorporated (DGX), valued at approximately $7.02 M.
As of the Q1 2026 filing, Quest Diagnostics Incorporated (DGX) represents approximately 1.53% of Robert Olstein's publicly disclosed stock portfolio, making it one of their key holdings.
Robert Olstein's peak holding in Quest Diagnostics Incorporated (DGX) was 100,000 shares, as reported at the end of Q1 2014.